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The prevalence of the coronavirus SARS-CoV-2 disease has resulted in the unprecedented collection of health data to support
research. Historically, coordinating the collation of such datasets on a national scale has been challenging to execute for
several reasons, including issues with data privacy, the lack of data reporting standards, interoperable technologies, and
distribution methods. The coronavirus SARS-CoV-2 disease pandemic has highlighted the importance of collaboration
between government bodies, healthcare institutions, academic researchers and commercial companies in overcoming
these issues during times of urgency. The National COVID-19 Chest Imaging Database, led by NHSX, British Society of
Thoracic Imaging, Royal Surrey NHS Foundation Trust and Faculty, is an example of such a national initiative. Here, we sum-
marise the experiences and challenges of setting up the National COVID-19 Chest Imaging Database, and the implications for
future ambitions of national data curation in medical imaging to advance the safe adoption of artificial intelligence in
healthcare.
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Introduction
Medical images have a central role in disease diagnosis,
predicting prognosis and risk stratification. Recent adv-
ances in computing power and a growth in the availability
of larger data repositories (including open-access datasets)
have led to an increase in the medical applications of artifi-
cial intelligence (AI) systems, with a focus on image ana-
lysis to support clinical pathways of care.1 These systems
aim to deliver similar image analysis functions to human
interpretation of medical imaging, as well as detect insights
beyond the capability of the human eye. In response to the
coronavirus SARS-CoV-2 disease (COVID-19), huge
efforts have been made by the deep learning community
analysing imaging datasets with the aim of enhancing the
certainty of COVID-19 diagnosis2,3 and improving
disease outcome prediction4,5 (such as ITU admission and
death) with varying levels of success.6,
7
,8 The main barriers
to the development of successful AI models have been the
variable quality of imaging data available for model train-
ing, and the limited amount of curated data that comprehen-
sively encompasses the variability of real-world clinical
cases necessary for robust model validation.
Until recently, the collection of imaging data to enable
the development of AI solutions in the UK has occurred
on a relatively limited scale, dependent largely on
bespoke local academic and commercial partnerships
within healthcare institutions.9 Homogenous but small data-
sets are expensive to curate and limit clinical validation of
AI tools using a wider study population.10,11 In this
regard, algorithms could be prone to biases12 such as
gender, ethnicity,13 socioeconomic status,14 and environ-
mental factors, which show the need for a well-diverse
dataset15 such as a national-scale dataset.
Larger national-scale imaging datasets covering
multiple geographic regions, using routinely collected
data and accessible to the wider community, have the
potential to enable development of more robust AI tools
where the data can help evaluate clinical questions, vali-
date AI algorithms and assess translational challenges.
The general lack of such datasets is cited as one of the
most significant challenges to the adoption of AI technol-
ogies in the NHS.16
In this paper, we discussed our experiences and chal-
lenges in setting up the National COVID-19 Chest
Imaging Database (NCCID). The NCCID was established
by the NHS AI Lab in May 2020 to combat the COVID-19
pandemic using AI technologies. It assimilates data of
over 15,000 patients from 22 NHS Trusts and Health
Boards to enable validation of AI algorithms.17,
18
,1 The
NCCID was endorsed by the Royal College of
Radiologists and aimed to provide a central repository
of chest X-rays, chest computed tomography (CT) scans
and cardiac magnetic resonance images (MRIs) of
COVID-19 diagnosed patients (through reverse transcrip-
tion polymerase chain reaction (RT-PCR) testing) and
controls.
Methodology
The experiences from the NCCID have emphasised that
there are opportunities to enhance the current UK health
data infrastructure for the national collection of medical
imaging data. This could be accelerated if led by a neutral
national healthcare body, such as NHSX in England, in
close collaboration with existing entities leading on data
collection initiatives in the UK (several of which are
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referenced in this paper) and the devolved administrations
in Scotland, Wales and Northern Ireland.19 These learnings
are summarised in Table 1.
A diagram and description of the infrastructure set-up for
the NCCID is also included in Figure 1.
Information governance: Rationalising data
governance processes to reduce the barrier to
participation in future national data collection
exercises
The NCCID’s data governance arrangements were estab-
lished quickly as a consequence of regulations put in
place for data collection during COVID-19. The notice
under regulation 3(4) of the Health Service (Control of
Patient Information) Regulations 2002 (COPI Notice),
valid for England and Wales until end of September
2021, enabled the NCCID to collect pseudonymised
patient data without seeking consent to support a
national response to the pandemic.20,21 Once the COPI
Notice expires, additional ethical approvals will need to
be acquired potentially through application to the
Confidentiality Advisory Group (CAG).22
In addition to compliance with the terms of the COPI
Notice, the NCCID has established robust data governance
procedures. Using the IG expertise of NHSX advisors and
project partners, in particular the National Consortium for
Intelligent Medical Imaging (NCIMI), the NCCID initiative
received formal ethical approval from the Health Research
Authority’s Research Ethics Committee to establish a
research database for the collection and sharing of the
NCCID data.23 Indeed using a research database model
was crucial in communicating the ethical basis of the initia-
tive to hospital sites to encourage participation. Ongoing
amendments became necessary as the data points collected
in the database expanded to keep pace with the rapid pro-
gression of scientific understanding around COVID-19.
These experiences highlight the comprehensive support
and expertise required to establish data governance arrange-
ments for national-level initiatives.
A Data Protection Impact Assessment (DPIA) is for-
mally shared with each participating hospital site alongside
a Data Sharing Agreement (DSA) for approval by Data
Protection Officers (DPOs). The national data opt-out
policy mandates that hospital sites should not upload data
for patients who have registered to opt-out of research
studies, and additional checks have been built in to the
NCCID’s data management procedures to ensure this data
is automatically deleted in rare instances where it is
mistakenly uploaded.24 Before accessing the database,
researchers must sign a Data Access Agreement and Data
Access Framework contract.
Information governance (IG) for national data colle-
ction is further complicated by the fact that legislation is
Table 1. Learnings summary from the National COVID-19 Chest
Imaging Database (NCCID) for future data collection initiatives.
Category Learning for future data collection
1 Information
governance (IG)
Data governance processes must
be clarified and standardised
to reduce barriers to NHS
Trust participation in
future national data collection
exercises
2 Database linkages Collaboration and linking with other
databases improve the quality,




3 Automation Incorporating automation is vital
to enable mass data collection
and reduce manual data






enables data to be accessed






Creation of large-scale high-quality
validation datasets helps to
accelerate the route to market
for new artificial intelligence
models
6 Funding Defining a variety of funding
mechanisms to support NHS
Trust data collection
activities and infrastructure
engineering is key to the
sustainability of any national
programme
7 Patient and public
engagement
Consulting patients and the
wider public is important to
ensure that concerns
regarding how patient data
is used and stored are
addressed and that this is




Defining benefit share frameworks
helps to ensure that the NHS
benefits at the local site level,
which can incentivise
participation in national data
collection exercises
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not consistent across the devolved administrations. For
example, the COPI Notice does not apply in Scotland,
where approval must be sought through the Public Benefit
and Privacy Panel (PBPP) instead. Navigating different reg-
ulatory procedures across UK territories inevitably delays
the ability to facilitate UK-wide imaging data collection.
In the short term, it would be beneficial for a neutral health-
care body to publish clear, available guidance for research-
ers to understand the necessary processes to be undertaken
when setting up data collection studies. In the long term,
collaboration across national organisations would help to
review existing data governance models and identify how
these can be streamlined to support researchers.25
Database linkages: Promoting discovery through
collaboration with other databases
The NCCID has been collaborating with other UK database
initiatives to improve the quality, completeness and cover-
age of the data collected. These are detailed in Table 2.
Linking the NCCID to other databases was achieved one
database at a time, and maintaining the necessary support
from IG experts, project managers, technologists and clini-
cians over a prolonged period is difficult to sustain.2
Establishing national-level infrastructure and processes to
integrate and allow communication between existing data-
sets will be important to leverage the potential of data col-
lected within the NHS. A number of initiatives in the UK
have made progress on this. The ambition of Health Data
Research UK (HDR UK) is to create a UK-wide approach
for the development of secure and transparent data services
through initiatives such as the Health Data Research
Figure 1. National COVID-19 Chest Imaging Database (NCCID) infrastructure and explanation.
Table 2. Database linkages for the National COVID-19 Chest Imaging
Database (NCCID).
Database linkage Objective





To enhance the number of
clinical variables that can
be evaluated alongside
clinical imaging and to
reduce duplication of data
gathering efforts for
hospital sites during a
period of stretched limited
resources.
2 NHS England and
Improvement
To provide comprehensive
ethnicity data, which can be
challenging to collect when
relying solely on hospital
records. Collecting reliable
ethnicity data is essential
given the disproportionate
impact of COVID-19 on the
Black, Asian and Minority
Ethnic (BAME) populations,




3 National Scottish Picture
Archiving and
Communications System
(PACS) and Safe Haven
Network62,63
To increase the geographic
coverage of the database to
the entirety of Scotland.64
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Innovation Gateway, a common discovery portal to UK
health research data for accredited researchers and innova-
tors.26,27 HDR UK is also working closely with other
Trusted Research Environments (TREs28) and Safe Haven
Environments to increase the discoverability of UK health
datasets and is promoting accessibility to vital COVID-19
datasets via the COVID-19 National Core Studies pro-
gramme.29 Our experience in the NCCID has highlighted
the national-level coordination required to overcome the
barriers of a fragmented data landscape by establishing
data access terms and processes that are common across
UK initiatives.303 Data federation is a potential solution,
which refers to the aggregation of different data sources
into a standard data format for users to access.31 This is a
long-term vision that will require national coordination to
be fulfilled, yet success will be key to leveraging the poten-
tial of data collected in the NHS.
Automation: Building infrastructure to enable
mass data collection and reduce manual data
capture for hospital staff
The NCCID project aims to reduce the burden on staff at
hospital sites by running a pilot exercise to automate
imaging data collection. To rapidly commence data
collection, the initial architecture of the NCCID pragmati-
cally relied upon Sectra’s Image Exchange Portal (IEP) as
processes for transferring images via this network are
well-known, resulting in minimal setup overhead at hospital
sites.32 To allow the automation of image transfer, Royal
Surrey NHS Foundation Trust (RSNFT) has deployed
SMART boxes at NCCID pilot sites, installed on either
physical hardware or a virtual machine, that act as a data
collection node at each site. The SMART box fulfils
three roles: (a) management of cases and clinical data
through an internal web portal, (b) image collection and
de-identification through a DICOM server, and (c) data
transfer to the central NCCID data warehouse. This
infrastructure, previously used to create large-scale
imaging databases such as the OPTIMAM Image
Database project, is significantly reducing workloads on
hospital PACS teams.33
The capture and storage of clinical variables are sup-
ported by technology and data standards that are less com-
prehensive and universal than those for images. The manual
processes to capture these data points utilise local staff or
informatics to collate the information from the local hos-
pital systems. Automating the collection of these clinical
data points by the NCCID has proved difficult due to the
heterogeneity of the clinical systems and integration pro-
cesses. The initiative is currently exploring possible
Table 3. Examples of existing initiatives facilitating collection of medical imaging data.
Data initiative Description of their work
1 National Consortium of Intelligent Medical Imaging (NCIMI) Led from Oxford’s Big Data Institute and brings together expertise
across 14 NHS partners, academia and 13 industry partners to
support the development, testing, validation and adoption of
new clinical imaging AI tools into the NHS.
2 PICTURES (Interdisciplinary Collaboration for the Efficient and
Effective Use of Clinical Images in Big Data Health Care
Research)
Led by the University of Dundee in conjunction with NHS Scotland
and other academic bodies. The study is collating 30 million
images from the Scottish National PACS, across all 14 Scottish
health boards, to support the development of AI technologies.
PICTURES will allow researchers to work on vast amounts of
data in a secure environment that protects individual patient
information.
3 East Midlands Radiology Consortium (EMRAD) Working with Kheiron Medical to develop and test a CE-marked
Mammography Intelligent Assessment (MIA) tool that can help
detect breast cancer, using the historic data and images
provided by EMRAD.65 Regional imaging networks are
increasingly able to facilitate the rapid testing and application of
machine learning technologies within large databases.66
4 Yorkshire Imaging Collaborative Partnered with Leeds University to develop a Trusted Research
Environment that extracts data from across the network to
predict future capacity and demand requirements for each
imaging modality across the region.67
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solutions to this challenge in addition to the data linkage
with ISARIC 4C.
The experiences of the NCCID demonstrate that a coor-
dinated UK-wide approach to automating components of
the data collection process across multiple use cases of
medical imaging could accelerate the development of AI
technologies. Numerous regional and national initiatives
are already underway including five new centres of excel-
lence aiming to enhance digital pathology and medical
imaging AI development and deployment,34 initiatives
such as PICTURES35 led by the University of Dundee in
conjunction with NHS Scotland and at a more local level,
radiology imaging networks such as EMRAD (see Table 3).
Given the wide-ranging initiatives that already exist in
the UK, there is an opportunity to establish national-level
linkage and discoverability to support combining such net-
works and datasets to enable, promote and support public
health research.
TREs: Building infrastructure to enable secure
data access for research
Ensuring that data can be accessed and analysed in a safe
and secure way is crucial to the successful development
of AI technologies. Data access can be organised by bring-
ing “the data to the users” or “the users to the data”. The
NCCID, due to the urgency presented by the pandemic
and the need to make data available at pace, adopted the
former approach, pushing data to users that are General
Data Protection and Regulation (GDPR) and security
compliant.
Bringing users to the data is a long-term ambition of
the NCCID, as it can help reassure both controllers of
healthcare data and the patient community that data is
being managed in a secure environment. This model is
increasingly adopted through the use of TREs, otherwise
known as Data Safe Havens. TREs ensure that all data
remains in infrastructure approved by the controller,
thereby making it easier to audit and ensure compliance
with IG standards. A number of initiatives in the UK
have supported research into TREs in recent years,
which have accelerated as a result of the data response
to COVID-19. The Scotland National Safe Haven pro-
gramme, Genomics England Research Environment and
the NHS Digital TRE for England are all examples of
enabling advances in TRE infrastructure design executed
against the ‘five safes’ – safe people, projects, settings,
data and outputs.4
However, progress remains to enhance TRE models to
better cater for the requirements of researchers and technol-
ogy developers, and adapting their functionality for scal-
ability.4 Users must be provided with the computational
resource, data storage and utilities necessary to do useful
work within the TRE itself, while preventing extraction of
provided data. TRE users should also have access to statis-
tical and data visualisation and annotation software tools,
the ability to access large virtual machines equipped with
graphical processing units (GPUs) and high performing,
flexible compute power to manage large volumes of data,
including imaging. Fair licensing and costing models are
also necessary to make data more widely available to the
public and commercial companies (the complexities of
such commercial models are explored further in the
Benefit share models: Defining frameworks to ensure that
data sharing directly benefits the NHS system section –
Benefit Share Models).36,37 All these factors will require
consideration in the future development of national
Table 4. Future aspirations to support the end-goal of




by a neutral national
body














3 Greater engagement with
the radiology community
as users of AI
To ensure that the AI tools
being prioritised for
deployment are designed
for optimal utility and
address the needs of
radiologists.
4 Further guidance and
support on regulatory





technology – to ensure that
AI products are deemed
safe and effective for use in
a clinical setting. NHSX has
already published an ‘AI
Buyers Guide’ to advise
commissioners of AI
technology on this matter,






To implement AI technologies





infrastructure to facilitate access to medical imaging data in
the UK.
Availability of validation datasets: Promoting
creation of large-scale high-quality validation
datasets
Automation can support data collection for national-level
validation datasets, which endeavour to capture an unbiased
representation of the UK population. Validation datasets
should ideally remain dedicated to the purpose of assessing
the performance of established AI models. However, within
the expansive research environment of the UK, it can be
challenging to ensure that a subset of the data within valida-
tion datasets has never previously been utilised for training
the same AI models that are to be validated.38 The creation
of an entirely segregated validation dataset to assess AI
technologies was a core objective at the centre of the
NCCID, which has yet to be fully realised. Due to the
urgency presented by the pandemic and the requests from
technology developers to share the NCCID data as soon
as it became available, assignment to the NCCID validation
dataset occurs via random sampling of patients. This initial
pragmatic choice allowed users access to validation data
while the NCCID was growing in scale, but once of a suffi-
cient size, the aim remains the provision of comprehensive,
tailored validation sets. This process will also need to
include image annotation, which is crucial for curating
high-quality datasets for medical image analysis.2
Hospital sites participating in the NCCID are asked to
confirm if they are sharing the data with other entities as
a way of understanding what data might have been used
in the development of an AI algorithm for COVID-19
research. If data has been shared with other entities, it is
excluded from the validation dataset. A consequence of
this policy is that it takes longer and requires numerous par-
ticipating hospital sites to build up a large enough valida-
tion sample that can be used to assess algorithms for
robustness.5 There is currently no easy solution to this
problem. To request a hospital site to set aside data,
which would have immediate value when used in local
studies, for the express purpose of allowing long-term cre-
ation of a national AI model validation dataset, is a signifi-
cant and probably unrealistic requirement. Hospitals may
also be reluctant to share data that could be used for com-
mercial purposes. There are a small number of examples
of UK studies that have managed to curate hold-out
unseen validation datasets, such as via the OPTIMAM
study, NCIMI, and the PROSPECTS trial, but it is by no
means common practice.39,40 However, one could argue
that the UK, with national oversight and systematic coord-
ination of health and care networks in the NHS, would be in
a unique position to develop hold-out validation datasets. A
nationally coordinated effort to define and implement best
practices for generating validation datasets would signifi-
cantly advance the path to independent robust validation,
which is currently lacking for CE marked solutions.
Robust validation in turn could speed up regulatory pro-
cesses for the licensing and deployment of AI technologies
in the UK.
Funding: Defining mechanisms to support data
collection activities and infrastructure engineering
as a research discipline
Understanding which funding mechanisms were the most
appropriate for the NCCID to pursue was difficult
because data collection as a pursuit in itself is not widely
recognised as clinical research in the UK. As the NCCID
required support from hospital Research & Development
(R&D) departments to facilitate collection of clinical data,
a number of sites recommended applying for inclusion on
the National Institute of Health Research (NIHR) Urgent
Public Health portfolio of studies, whereby hospital
resources can be diverted towards supporting prioritised
initiatives. However, the NCCID was deemed unsuitable
for Urgent Public Health badging, resulting in some sites
declining participation due to a lack of capacity among
local research staff during the pandemic.
There are also challenges with sourcing research nurses
or research coordinators for radiology studies specifically
and with setting up such studies in radiology departments,
as there is a significant shortage of radiology staff
members.41,
42
To date, apart from hospital sites that reallo-
cated or sourced in-house funding, the NCCID initiative has
only received funding from NHSX and has predominantly
relied on voluntary support from hospital sites to contribute
data. This model has sufficed due to the urgency presented
by the pandemic, but would be unsustainable for long-term
mass collection of imaging data. Further support and col-
laboration at a national level are required to establish
funding models that are specifically designed for national
data collection infrastructure, including imaging, as a
research discipline in its own right.
Patient and public engagement: Consulting
patients and the wider public on the requirements
and benefits of algorithmic development in
medical imaging
The adoption of AI technologies in medical imaging, parti-
cularly with the input of imaging specialists such as radiol-
ogists, can have considerable benefit for patients and the
healthcare sector where over 100,000 imaging studies are
performed daily in the UK.43,44 The 2019 Clinical
Radiology Workforce census highlights increases in work-
force shortages, with seven out of 10 clinical directors of
UK radiology departments expressing the view that there
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were insufficient numbers of clinical radiologists to be able
to deliver safe and effective patient care.6 AI tools may
improve the accuracy of diagnosis and the estimation of
likely prognosis for a patient in some settings, as well as
potentially improve efficiencies by speeding up screening
processes and reducing the number of human readers
required.7 However, despite data used in AI software
development being de-identified, there are understandable
concerns with how patient data is stored and used, particu-
larly for purposes that result in profit for commercial
organisations.
For the NCCID specifically, the Data Access Committee
includes ethical and patient advisors, who participate in the
review and approval of all applications to access the data-
base.45 This ensures that the patient viewpoint is always
considered before a decision is made to share data with
the requesting applicant. The public are also kept informed
on the projects that the NCCID data is currently supporting
through study publications on the NCCID website, which is
important for patients to understand how their data is being
used.46
The Patient and Public Involvement and Engagement
(PPIE) methods adopted for the NCCID will be expanded
in future. NHSX is working with the National Data
Guardian (NDG) and the Department of Health and
Social Care to use medical imaging as a case study for
exploring public attitudes towards the sharing of health
and social care data for data-driven research and innovation
in England.47 NHSX also plans to collaborate with the Ada
Lovelace Institute to trial a model for algorithmic impact
assessments. Such assessments will involve public engage-
ment on AI solutions developed using medical imaging data
and encourage innovators to review and refine their pro-
ducts based on discussions with citizens about its ethical
and societal implications.48 These mechanisms are useful
for understanding the public perceptions of using data to
develop and test algorithms, and the level of trust felt
towards algorithms in clinical care supporting the role of
human readers.49 More targeted research and public con-
sultation on the impact of this is needed to support the suc-
cessful adoption of AI technologies in medical imaging at
scale in the UK.
Benefit share models: Defining frameworks to
ensure that data sharing directly benefits the NHS
system
NHS data used in the development and validation of AI
imaging algorithms should result in improved patient
care. At the same time, the NHS needs to receive fair
value from the data assets that it holds. There has been
much discussion of the forms this value might take, and
can include clinical, social, economic development, envir-
onmental and commercial value. The commercial value
can itself take a range of forms, including monetary, intel-
lectual property (IP) ownership, and equity and royalties
from any products developed, all of which can be achieved
via payment or in the form of beneficial access terms for the
NHS.50 It is important to create the right frameworks to
identify and realise the benefits for patients and the NHS
where data underpins innovation, with an increasing focus
on establishing a new ‘social contract’ to achieve this.51
Due to the severity of the COVID-19 pandemic, the
NCCID has established a contractual arrangement with
approved data users whereby data is provided to the user
free of charge, but any related technologies developed as
a result of this must be provided at zero-licence fee cost
to the NHS for the duration of the Data Access
Agreement signed by the data user. Importantly, all appli-
cants must be able to demonstrate that their proposal will
directly benefit the NHS to be granted access. This model
aims to expedite the development of potentially useful
tools, which is crucial in the context of COVID-19
but may not be appropriate for non-COVID-19-related
technologies.
Another benefit share model that has the potential to
accelerate the development of AI technologies52 contractu-
ally requires data users to share derived data such as image
annotations from their analysis for the benefit of all
researchers. High-quality image labelling, often performed
as an internal exercise within a research group, can be time-
consuming and expensive to create. Trained experts may be
necessary to annotate the images or check the annotations
created by automated tools.53 High-quality annotation is
vital for supervised training, testing and validation of AI
algorithms, and there may be inherent benefits in openly
sharing the outputs of image annotation from multiple
expert sources with the wider research community. The
national influence and scale of the NHS mean that it is sui-
tably positioned to encourage the open sharing of annotated
datasets in the UK through collaborations with research
consortiums and industry partners.
It is also important to consider a more direct form of
benefit share model for hospital sites at a local level.
Hospital sites may show greater willingness to commit
resources and expertise to support commercial companies
if they are able to directly benefit from the technology in
return. Existing research databases have utilised these
models through direct income share models, with hospital
sites gaining income through commercial licensing of
data and images. Collection sites sign an assignment agree-
ment giving the study a non-exclusive licence to include the
images and data in the research database and proportions of
income shared is calculated based on contributions from the
participating sites and the characteristics of the data
submitted.54
NHSX is currently focusing on defining the terms of
such benefit share models. The Life Sciences Industrial
Strategy has set out guiding principles for sharing health
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and care data that emphasises that data has to be used for the
purpose of improving patient care and that any arrange-
ments need to be clearly and transparently communicated.55
Providing assurance to the public on the ethical basis for
sharing data, involving them in a transparent dialogue and
informing them of the direct public benefit are important
strategies that need to be widely adopted.56 The NHSX-
led Centre for Improving Data Collaboration has been set
up to provide direct support to the health and care sector
to meet these guiding principles and establish frameworks
for achieving fair value for the NHS.57 Importantly,
further research is needed to define the different types of
benefit share models that should apply to commercial devel-
opers in the UK depending on the different use cases that
the data is being shared for, for example, whether it is a
public health emergency or a rare disease, and the intended
scale of the deployment.58
Future aspirations
The experiences of the NCCID have resulted in valuable
learnings to inform a national-level data collection
approach for AI development in medical imaging. There
are several areas that will need focus, which will be key
to ensure that the benefits of data collection are realised
through the implementation of AI technologies in real-
world settings (see Table 4).
NHSX will be working closely with research groups,
technology companies and NHS Trusts to progress the
above focus areas through the work of the NHS AI Lab.
Conclusions
Establishing the NCCID during the COVID-19 pandemic
has emphasised the challenges that exist when setting up
national data collection infrastructure in the UK, but has
also emphasised future opportunities for advancing the
development and adoption of AI technologies in medical
imaging. These opportunities relate to (a) improving
access to high-quality data, (b) supporting impactful
research objectives, and (c) facilitating better integration
between the NHS and the entrepreneurial community to
identify life-saving solutions. Robust and clear data govern-
ance structures are a requisite to support the legal and
ethical basis for data collection. Automated data pipelines
to build large-scale datasets for training and validating AI
technologies will require national coordination and infra-
structure expertise. TRE models will need to be enhanced
through targeted support and closer integration to facilitate
easier access to national datasets for research and technol-
ogy development. All of this work will require consistent
funding at a national level and support from the general
public, along with patient advocacy groups, to realise
impact. As one of the few countries to offer a publicly
funded, single payer, nationwide healthcare system, the
UK is optimally positioned to be a global leader in national
data infrastructure for medical imaging to support AI devel-
opment and deployment into clinical pathways and to dem-
onstrate how care can be improved as a result.8 Ultimately,
the success of this endeavour will be dependent on national
collaboration between NHS executives, clinicians, patients,
researchers and technology companies, and the NHS AI
Lab is well placed to coordinate these diverse stakeholders
to drive this initiative forward.
If you work at a hospital site and are interested in con-
tributing data to this initiative, please reach out directly to
imaging@nhsx.nhs.uk.
If you are involved in research or technology develop-
ment and would like to apply for access to the NCCID train-
ing dataset, please follow the instructions at this link:
https://nhsx.github.io/covid-chest-imaging-database/.
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